These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 28508374

  • 1. AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study.
    El-Hachem N, Haibe-Kains B, Khalil A, Kobeissy FH, Nemer G.
    Methods Mol Biol; 2017; 1598():391-403. PubMed ID: 28508374
    [Abstract] [Full Text] [Related]

  • 2. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS, Akhtar S, Danish Rizvi SM, Kamal MA, Sayeed U, Khan MKA, Siddiqui MH, Arif JM.
    Curr Comput Aided Drug Des; 2017 Nov 10; 13(4):311-318. PubMed ID: 28413992
    [Abstract] [Full Text] [Related]

  • 3. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ, Roy A, Jung HJ, Ali MY, Min BS, Park CH, Yokozawa T, Fan TP, Choi JS, Jung HA.
    J Ethnopharmacol; 2016 Aug 22; 190():219-30. PubMed ID: 27275774
    [Abstract] [Full Text] [Related]

  • 4. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ.
    Nat Protoc; 2016 May 22; 11(5):905-19. PubMed ID: 27077332
    [Abstract] [Full Text] [Related]

  • 5. Using AutoDock for ligand-receptor docking.
    Morris GM, Huey R, Olson AJ.
    Curr Protoc Bioinformatics; 2008 Dec 22; Chapter 8():Unit 8.14. PubMed ID: 19085980
    [Abstract] [Full Text] [Related]

  • 6. Acylguanidine-BACE1 complex: Insights of intermolecular interactions and dynamics.
    Saravanan K, Kumaradhas P.
    J Theor Biol; 2019 Mar 07; 464():33-49. PubMed ID: 30571961
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
    Kumar A, Roy S, Tripathi S, Sharma A.
    J Biomol Struct Dyn; 2016 Mar 07; 34(2):239-49. PubMed ID: 25707809
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study.
    Chakraborty S, Kumar S, Basu S.
    Neurochem Int; 2011 Jul 07; 58(8):914-23. PubMed ID: 21354237
    [Abstract] [Full Text] [Related]

  • 17. Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical in virtual screening.
    Manoharan P, Chennoju K, Ghoshal N.
    Mol Biosyst; 2015 Jul 07; 11(7):1955-72. PubMed ID: 25927726
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.